17 - A first-in-human phase I study of sEphB4-HSA in patients with advanced solid tumors with expansion at the maximum tolerated dose (MTD) or recommended phase II dose (RP2D)
| Autor: | El-Khoueiry, A., Gitlitz, B., Cole, S., Tsao-Wei, D., Goldkorn, A., Quinn, D., Lenz, H.J., Nieva, J., Dorff, T., Oswald, M., Berg, J., Menendez, X., Karakozian, K., Krasnoperov, V., Liu, R., Thomas, J., Groshen, S., Gill, P. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S11-S11 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect